Burning Rock Biotech's IFRS loss for 9M 2021 was CN¥545.553 million, up 2.2 times from CN¥250.757 million in the previous year. Revenue increased 20.9% to CN¥360.517 million from CN¥298.181 million a year earlier.
Burning Rock Biotech's IFRS loss for 9M 2021 was CN¥545.553 million, up 2.2 times from CN¥250.757 million in the previous year. Revenue increased 20.9% to CN¥360.517 million from CN¥298.181 million a year earlier. 
ir.brbiotech.com
English (US) 